The cancer program at the John B. Amos Cancer Center of Columbus Regional Healthcare System recently achieved three-year accreditation status by two national accrediting agencies. The Commission on Cancer granted the comprehensive cancer program a Three-Year Accreditation with Commendation, while the American College of Radiation Oncology awarded full accreditation to John B. Amos Cancer Center's Radiation Oncology Practice.
"We are pleased that our cancer program has met, and in many cases exceeded, the stringent standards of these accrediting bodies," said Andrew Pippas, M.D., Medical Director for the John B. Amos Cancer Center. "For our Cancer Center, this means that our team, technology, quality measures, clinical research and all the other elements that comprise our program have earned two national gold seals of approval. But more importantly, these accreditations assure our community that they have access to superb cancer care right here in Columbus."
To achieve the Commission on Cancer's Three-Year Accreditation with Commendation, the John B. Amos Cancer Center participated in a comprehensive on-site evaluation conducted by a physician surveyor. The surveyor evaluated all aspects of the program, and determined a commendation level of compliance with one or more standards that represent the full scope of the cancer program, including the cancer committee leadership, cancer data management, clinical services, research, community outreach, and quality improvement. In addition, the John B. Amos Cancer Center received a compliance rating for all other standards.
Similarly, the American College of Radiation Oncology conducted an on-site review and data analysis to ascertain that the equipment, staff, policies, procedures and treatment program of the John B. Amos Cancer Center's radiation practice meet the accepted standards of modern day radiation therapy delivered in the United States. The survey and data analysis were conducted by board-certified radiation oncologists and radiation physicists active in ACRO'S Practice Accreditation Program.
"We are extremely proud to have achieved accreditation through both the Commission on Cancer and the American College of Radiation Oncology," said Matt Sherer, Administrative Director of the John B. Amos Cancer Center. "These accreditations demonstrate the commitment of our staff, physicians, and Columbus Regional to provide world class care here in Columbus. As a community-based, not-for-profit, cancer program, these important accreditations mean cancer patients within our community are assured access to the high-quality and comprehensive care they need close to home."
About the John B. Amos Cancer Center
The John B. Amos Cancer Center, a part of Columbus Regional Healthcare System, is the leading cancer treatment facility in Southwest Georgia, offering outpatient medical and radiation oncology, infusion therapy, an oncology pharmacy, and support services for patients and their families. The center reported nearly 1,200 new patients during last fiscal year (July 2009-June 2010), including approximately 700 new cases in Radiation Oncology. There were more than 161,000 total patient visits – a 12 percent increase over the previous year. The center recorded more than 21,000 patient visits in Medical Oncology, more than 67,500 in Infusion and almost 48,000 in Radiation Oncology.
About the Commission on Cancer
Established in 1922 by the American College of Surgeons, the Commission on Cancer is a consortium of professional organizations dedicated to improving survival rates and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons and 42 national organizations that reflect the full spectrum of cancer care.
Receiving care at a Commission on Cancer-accredited cancer program ensures that a patient will have access to comprehensive care, including a range of state-of-the-art services and equipment; a multi-specialty, team approach to coordinate the best treatment options; information about ongoing clinical trials and new treatment options; access to cancer-related information, education and support; a cancer registry that collects data on type and state of cancers and treatment results and offers lifelong patient follow-up; ongoing monitoring and improvement of care; quality care close to home.